Siga Technologies announces joint procurement mechanism by EC

SIGA Technologies announced the creation by the European Commission’s, EC, DG HERA of a joint procurement mechanism under which 13 participating countries from the European Union and the European Free Trade Association can efficiently order oral TPOXX. Based on commitments from EU member countries, it is currently anticipated that $18 million in approximate value of oral TPOXX will be initially ordered by EU countries under this mechanism within the next 60 days. Orders through the joint procurement mechanism will result in country-level procurement of oral TPOXX. Under the joint procurement mechanism, countries in the EU will acquire courses of oral TPOXX in the near term, and be able to efficiently order additional courses of oral TPOXX in the future as long as minimum quantity thresholds are met. “With the creation of a joint procurement mechanism, there are now multiple paths in Europe for efficient procurement of oral TPOXX,” said Phil Gomez, CEO of SIGA. “These protocols, through which every country in the EU can access oral TPOXX, highlight the importance of addressing the long-term impact and risks of orthopox viruses such as smallpox and monkeypox.” Orders under the joint procurement mechanism are expected to bring total TPOXX orders in 2023 to approximately $164 million. A substantial percentage of these orders are expected to be delivered in 2023.